Pages that link to "Q38481524"

The following pages link to Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer (Q38481524):

Displaying 24 items.

• The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival (Q24600187) (← links)
• The genetics of transitional cell carcinoma: progress and potential clinical application (Q33723575) (← links)
• Molecular aspects of bladder cancer III. Prognostic markers of bladder cancer (Q34630648) (← links)
• Current understanding of the biology of advanced bladder cancer (Q35097977) (← links)
• Molecular prognostication in bladder cancer--a current perspective. (Q35175438) (← links)
• Molecular biology of transitional cell carcinoma (Q35192420) (← links)
• Frequent and heterogenous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma (Q36291667) (← links)
• Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers (Q36363225) (← links)
• Genetic alterations in urothelial bladder carcinoma: an updated review (Q36393012) (← links)
• Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors (Q37116089) (← links)
• Biomarkers in bladder cancer: present status and perspectives. (Q37281006) (← links)
• Molecular targets and targeted therapies in bladder cancer management. (Q37336643) (← links)
• Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer (Q37743536) (← links)
• ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistance (Q38729065) (← links)
• CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma (Q39218849) (← links)
• Fibulin-5 is down-regulated in urothelial carcinoma of bladder and inhibits growth and invasion of human bladder cancer cell line 5637. (Q39797258) (← links)
• Prognostic markers in bladder cancer: a contemporary review of the literature (Q40844938) (← links)
• E-cadherin involved in inactivation of WNT/beta-catenin signalling in urothelial carcinoma and normal urothelial cells (Q42132340) (← links)
• Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma (Q43001429) (← links)
• Exploration of genetics commonness between bladder cancer and breast cancer based on a silcio analysis on disease subtypes. (Q55423400) (← links)
• c-myc in bladder cancer. Clinical findings and analysis of mechanism (Q73174813) (← links)
• Over-expression and amplification of the c-myc gene in human urothelial carcinoma (Q74649765) (← links)
• Molecular pathways in bladder cancer (Q81024663) (← links)
• Qici Sanling decoction suppresses bladder cancer growth by inhibiting the Wnt/Β-catenin pathway (Q92549919) (← links)